🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this research study is to assess whether the partici...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2013-07
Trial ID
NCT01822691
Treatments Being Tested
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914
This phase II trial studies how well pembrolizumab and epacadostat work in ...
Status
Completed
Location
Anchorage Associates in Radiation Medicine
Start Date
2018-12-21
Trial ID
NCT03602586
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of pembro...
Status
Completed
Location
Arizona Oncology Associates PC- HOPE
Start Date
2017-12-04
Trial ID
NCT03361865
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of the com...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-12-15
Trial ID
NCT03342352
Treatments Being Tested
Background: Immunotherapy drugs help the body to fight cancer. Scientists ...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2018-05-01
Trial ID
NCT03493945
This is an open-label, randomized, phase 2 study of an IDO inhibitor, INCB0...
Status
Terminated
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01685255
Treatments Being Tested
This is an open label, dose escalation study using a 3 + 3 design to determ...
Status
Completed
Location
Multiple Locations
Start Date
2010-07
Trial ID
NCT01195311
Treatments Being Tested
The purpose of this study is to explore the safety, tolerability, pharmacok...
Status
Completed
Location
Multiple Locations
Start Date
2015-01-05
Trial ID
NCT02318277
Treatments Being Tested
The study design included an open-label, dose escalation phase followed by ...
Status
Terminated
Location
Multiple Locations
Start Date
2012-03-29
Trial ID
NCT01604889
Treatments Being Tested